about
Multidrug-resistant bacteria in solid organ transplant recipientsWhat is healthcare-associated pneumonia and how is it managed?Impact of an Educational Program to Reduce Healthcare Resources in Community-Acquired Pneumonia: The EDUCAP Randomized Controlled TrialUsefulness of simulated cases for assessing pandemic influenza preparedness plans.Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia.Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.Influenza A(H1N1)pdm09: beyond the pandemic.Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Risk factors and outcomes of organ-space surgical site infections after elective colon and rectal surgery.Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study.Management of community-acquired pneumonia in older adults.Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI cohort.Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.Effect of statin use on outcomes of adults with candidemia.Molecular epidemiology of nontypeable Haemophilus influenzae causing community-acquired pneumonia in adults.Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisDaptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.Causes of death in a contemporary cohort of patients with invasive aspergillosisEffect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trialGroup B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review.The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation.Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrosStatins for community-acquired pneumonia: current state of the science.An update on Legionella.Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus.Severe, non-bacteremic infections in ICU patients.GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.Advances in antibiotic therapy for community-acquired pneumonia.
P50
Q26822729-A9830FBC-5FE8-4027-9393-294F91C552B8Q28271360-FFFD5164-47F5-42D4-B1E1-4674625A5C94Q28550197-4A5B00AC-7E13-4537-8A48-F7FBE5DE0078Q30227357-EEB58122-8EA6-44D6-90B2-85A76E2B210AQ30362392-048916E5-1F26-455E-9B11-E626CFAF80E3Q30381799-5BF927C9-0D54-4479-A30A-CFE6976F6F71Q30399360-A5D8C612-C78B-4B70-A2D8-ABC2FC0AB7CFQ30400874-09B2B5D1-EFB7-4205-A8BF-8212C9393F6BQ30423112-2DBCCF00-0E46-4F15-892D-9722D2E1F18AQ30431627-0071183F-2834-4069-A140-81447C7A764AQ30608976-0BEE20A0-5471-4452-B0B5-DECF55337292Q33592593-B9B45519-C591-4B13-B168-42555FAB1807Q33633380-522B3283-A30F-4D98-AB48-92E82BC59E01Q33810591-893D05E8-6A89-4014-8398-55F541AC714BQ34003488-90B4D958-5357-4311-B609-1242C3F1FCEAQ34105094-6F892C80-2455-4207-B574-81D649C8B681Q34683959-F61F1BD1-92F5-4DA5-B0A8-B88782B8456CQ34903761-98D73A3B-515D-4AE1-B8A9-5DB7B5FA0DA4Q34999291-CF77B822-E5BE-4EB1-8E7F-5F42EC575A14Q35025431-B31DA32C-0923-4CE3-8569-63F73AECF629Q35070330-4FE22CE5-655E-44E4-A732-30F0A59EEF11Q35122694-CC6D9F98-550E-4261-8761-7EB8EC926A46Q35179800-BB48E374-68F3-40D4-AD5A-18EEC7149BD8Q35213770-045BA56C-E9FD-4146-A895-B55A458FF458Q35559463-9ED75A4D-8B29-49B6-B993-A3697DCE1013Q35676384-661A5DF6-0F80-49F9-ABA2-4B9176E86AFCQ35865273-716378BC-FAC0-4733-BA12-4D1310F8DC79Q36101533-50D8B15C-6078-4A30-AE6F-EFCD0B2E51A9Q36247827-BF56FADC-9163-4C34-A927-0702AB562920Q36466631-7DCD84DB-7A32-4124-9B6E-49F76A83FE58Q37177518-84470B5D-14CB-468B-B10E-24493B73B349Q37612207-05BDBE2C-BB05-4013-90B3-1DAE04E6925EQ37639928-F39BED7F-B182-485F-A6E6-7B821DBC102BQ37669060-23CA9055-74CA-4CA8-B697-9E130D37AB18Q37696804-3EC4CCDB-982D-456B-831F-2AFCD028D9BBQ37726612-B7607E1B-959C-42BA-92B3-B327E405B01FQ37860553-F2D594C8-4373-4F95-8089-6EF552628ECCQ37934102-C8E4AE95-4C7A-4278-B914-C61FE0E84AF5Q38006193-836CB51E-593F-4E0B-8993-A2055DBD79F0Q38082927-6DD627A5-82CA-44FA-BDCA-961A9461A0E1
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jordi Carratala
@ast
Jordi Carratala
@en
Jordi Carratala
@es
Jordi Carratala
@nl
Jordi Carratala
@sl
type
label
Jordi Carratala
@ast
Jordi Carratala
@en
Jordi Carratala
@es
Jordi Carratala
@nl
Jordi Carratala
@sl
prefLabel
Jordi Carratala
@ast
Jordi Carratala
@en
Jordi Carratala
@es
Jordi Carratala
@nl
Jordi Carratala
@sl
P214
P950
P106
P1580
P21
P214
P31
P496
0000-0003-3209-2563
P735
P7859
viaf-86598865